BOTPPF
BMRN icon

Board of the Pension Protection Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Board of the Pension Protection Fund’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,900
Closed -$157K – 255
2025
Q3 		$157K Sell
2,900
-5,200
-64% -$297K 0.15% 133
2025
Q2 		$445K Buy
+8,100
New +$477K 0.48% 74

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Board of the Pension Protection Fund's BMRN Position: Q4 2025 in Review

Board of the Pension Protection Fund sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 2,900 shares — an estimated $157K sold.

Board of the Pension Protection Fund first reported a position in BMRN in Q2 2025 and held it in 2 quarters. The position peaked at $445K in Q2 2025. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

  • Board of the Pension Protection Fund reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Board of the Pension Protection Fund sold 2,900 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $157K.
  • Board of the Pension Protection Fund first reported a position in BioMarin Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Board of the Pension Protection Fund's BioMarin Pharmaceuticals position peaked at $445K in Q2 2025.
  • 539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Board of the Pension Protection Fund's 13F filing for Q4 2025, filed 6 Jan 2026.